← Leaderboards
Anil Kumar Goyal
Immvention Therapeutix, Inc.
$138,609
Attributed
$277,218
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$277,218 · 1
By mechanism
R41$277,218 · 1
Top collaborators
- Kristy M Ainslie1 shared
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAgonistAntibodiesAntibody ResponseAntigen-Presenting CellsAntigensAntiviral AgentsAttenuatedBaseBiopolymersBirdsBody WeightBronchitisCd8-Positive T-LymphocytesCellular ImmunityCenters For Disease Control And Prevention (U.S.)Cessation Of LifeCharacteristicsComplexCostCross ReactivityCytokineDependenceAcute